Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Tulisokibart for Psoriatic Arthritis in Adults

    Recruiting

    2 1
    Investigated drugs:
    Germany Poland Spain
  • A study to evaluate the effectiveness and safety of JNJ-88545223 in people with active psoriatic arthritis

    Recruiting

    2 1
    Czechia Germany Hungary Poland Spain
  • Study of Janus kinase inhibitor dose reduction in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis who have achieved low disease activity

    Recruiting

    3 1 1 1
    The Netherlands
  • Study on Lutikizumab and Risankizumab for Adults with Active Psoriatic Arthritis

    Recruiting

    2 1 1
    Investigated drugs:
    Czechia France Hungary Poland
  • Study on the Effects of Upadacitinib for Patients with Active Psoriatic Arthritis and Axial Spondyloarthritis

    Recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Belgium Poland
  • Study on the Effectiveness and Safety of Zasocitinib (TAK-279) for Patients with Active Psoriatic Arthritis with Previous Biologic Treatment

    Recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    France Germany Poland Spain
  • Study of Zasocitinib and Apremilast for Adults with Active Psoriatic Arthritis Who Have Not Used Biologic Medicines

    Recruiting

    3 1 1
    Investigated drugs:
    Belgium Bulgaria Croatia Czechia Estonia Germany +6
  • Study on the Effectiveness and Safety of JNJ-77242113 for Patients with Active Psoriatic Arthritis Who Have Previously Used Biologic Treatments

    Recruiting

    3 1
    Investigated drugs:
    Bulgaria Czechia Denmark Germany Hungary Italy +3
  • Study on the Effects of Sonelokimab in Patients with Active Psoriatic Arthritis or Axial Spondyloarthritis

    Recruiting

    2 1 1
    Investigated diseases:
    Germany
  • Study of sonelokimab and risankizumab in adults with psoriatic arthritis who did not respond well to previous TNF inhibitor treatment

    Recruiting

    3 1 1
    Investigated drugs:
    Bulgaria Czechia France Germany Hungary Poland +1